Bausch Health Cos Price to Free Cash Flow Ratio 2010-2024 | BHC

Historical price to free cash flow ratio values for Bausch Health Cos (BHC) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bausch Health Cos Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-02-28 7.44 2.17
2024-12-31 8.06 $3.42 2.35
2024-09-30 8.16 $2.88 2.83
2024-06-30 6.97 $2.63 2.65
2024-03-31 10.61 $2.30 4.62
2023-12-31 8.02 $2.24 3.58
2023-09-30 8.22 $2.55 3.22
2023-06-30 8.00 $-1.73 0.00
2023-03-31 8.10 $-2.02 0.00
2022-12-31 6.28 $-2.61 0.00
2022-09-30 6.89 $-3.81 0.00
2022-06-30 8.36 $2.94 2.85
2022-03-31 22.85 $3.72 6.15
2021-12-31 27.61 $5.09 5.43
2021-09-30 27.85 $6.12 4.55
2021-06-30 29.32 $3.43 8.56
2021-03-31 31.74 $2.81 11.29
2020-12-31 20.80 $2.34 8.90
2020-09-30 15.54 $1.83 8.48
2020-06-30 18.29 $2.66 6.87
2020-03-31 15.50 $3.11 4.99
2019-12-31 29.92 $3.62 8.26
2019-09-30 21.85 $3.91 5.58
2019-06-30 25.22 $5.84 4.32
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.638B $9.625B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.010B 6.96
Dr Reddy's Laboratories (RDY) India $11.261B 21.48
BridgeBio Pharma (BBIO) United States $6.894B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.805B 24.57
Amphastar Pharmaceuticals (AMPH) United States $1.553B 9.33
Taysha Gene Therapies (TSHA) United States $0.338B 23.57
Personalis (PSNL) United States $0.323B 0.00
Assembly Biosciences (ASMB) United States $0.080B 0.00
Sol-Gel Technologies (SLGL) Israel $0.016B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00